American Pharmacists Association Foundation and NOWDiagnostics Launch Nationwide Real-Time Pharmacy COVID-19 Antibody Test with ADEXUSDx® Rapid Test Targeted on Advanced Proteins
In 2021, the APhA Foundation, a supporting foundation of the American Pharmacists Association – the leading association of pharmacists in United States, launched the IMPACT Care Transformation Network, which enables partner pharmaceutical firms to collaborate on scaling up innovative models of care through infrastructure and opportunities that enable pharmacists to provide and be paid for innovative services. Pharmacies in the IMPACT network can now start offering ADEXUSDx® COVID-19 antibody test to interested patients, who will get results via RxTest from the APhA.Solutions Foundation™ that allow consumers and healthcare providers secure access to results through an innovative technology platform (see https://IMPACT.CareTransformation.Network for more information).
“The APhA Foundation is pleased to offer the ADEXUSDx COVID-19 antibody test in our IMPACT network pharmacies across the country in collaboration with RxTest.Solutions™, and we know pharmacists will use the test to continue to provide exceptional patient care. Becoming aware of their antibody status resulting from an actual vaccination or illness provides another valuable piece of information that could help patients make informed decisions, as well as the advice of their health care provider, as to the treatment. best course of action in their healthcare journey. As has been demonstrated since the onset of the pandemic, the care provided by pharmacists is essential to public health and the well-being of communities all over the world, and we believe this opportunity with NOWDiagnostics and the APhA Foundation presents a another great way for pharmacists to serve their patients and their communities ”, mentioned Benjamin M. Bluml, RPh, Senior Vice President, Research and Innovation, American Pharmacists Association Foundation.
ADEXUSDx® The COVID-19 antibody test detects antibodies that bind to the receptor binding domain (RBD) subunit of the S1 spike protein of the SARS-CoV-2 virus. The most protective antibodies develop against this part of the S1 spike protein domain and are induced by vaccination. Other antibody tests, designed to detect nucleocapsid antibodies, will not detect antibodies caused by the vaccine, only those caused by natural infection. Although the Food and Drug Administration (FDA) has not yet issued guidelines for companies to conduct the trials necessary to claim the determination of the antibody response due to vaccination and therefore has not authorized any antibody testing. for this specific indication, ongoing studies have identified people who test positive for anti-COVID-19 antibodies with ADEXUSDx® COVID-19 antibody test, and who did not report previous COVID-19 illness but received a COVID-19 vaccine.
Kevin Clark, CEO of NOWDiagnostics, said: “It is a privilege to partner with the APhA Foundation to bring an important COVID-19 testing solution to pharmacists in our country, one of the most trusted groups of healthcare professionals. We are grateful for the important work pharmacists have done on the front lines, providing vaccines to prevent the spread of COVID-19. We are pleased to provide them with another important tool to ensure the health and safety of their patients. “
Since the start of the COVID-19 pandemic, reliable antibody tests have played a central role in identifying recovering plasma donors to provide life-saving therapy to those most affected by COVID-19. In addition to this role, antibody tests offer important utility in understanding immunity after infection, and potentially therapy and vaccination, for individuals, healthcare providers, businesses, the community and organizations. governments. However, it is not known at this time whether the presence of antibodies to SARS-CoV-2, as determined by this test and others, confers immunity to infection.
In May 2021, NOWDiagnostics announced that it has received Emergency Use Clearance from the Food and Drug Administration (FDA) for ADEXUSDx® Use of COVID-19 test in complex moderate and point-of-care environments. In August 2020, this project was funded in whole or in part with federal funds from the Department of Health and Social Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, Division of Research Innovation and Ventures under contract n ° 75A50120C00156 with NOWDiagnostics for the development of ADEXUSDx® COVID-19 test. Trials for over-the-counter use are underway.
About the American Pharmacists Association Foundation
The American Pharmacists Association Foundation (APhA), a 501 (c) (3) nonprofit charitable organization based in Washington, DC, works to design solutions to optimize drug use and delivery of care in America. The APhA Foundation is affiliated with the American Pharmacists Association, the oldest and largest national professional society of pharmacists in the United States, established in 1852. The mission of the APhA Foundation is to improve health by inspiring philanthropy, research and innovation that advance pharmacists’ patient care services. . For more information, please visit www.aphafoundation.org.
About NOWDiagnostics, Inc .: NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostic tests. Its ADEXUSDx® The product line includes a lab at your fingertip, using a single drop of blood to test a variety of common ailments, diseases and illnesses, with results within minutes. By eliminating the need to send tests to offsite laboratories, NOWDiagnostics products have the potential to reduce the waiting period to determine test results by several days. For more information on NOWDiagnostics, visit www.nowdx.com. For more information on ADEXUSDx® The COVID-19 test, including its intended use, features, benefits, and directions for use, visit www.c19development.com. ADEXUSDx® The COVID-19 test will be distributed by C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics. Laboratories can contact www.c19development.com/order to place an order.
SOURCE NOW Diagnostics